Thomas Strüngmann

Thomas Strüngmann was the founder of ATS Beteiligungsverwaltung GmbH, founded in 2006, serving as Chief Executive Officer from 2010 to 2018.
Dr. Strüngmann was the founder of Hexal AG, founded in 1986, serving as Unternehmensgründer from 1986 to 2010.
Dr. Strüngmann is also the founder of AT Newtec GmbH..
Dr. Strüngmann currently holds the position of Co-Managing Director at Klinge Pharma GmbH.
Dr. Strüngmann currently holds the position of Co-Managing Director at Dr. Ernst Strüngmann Foundation gGmbH.
Dr. Strüngmann currently holds the position of Co-Managing Director at Projektgesellschaft St. Anna 16 mbH.
Dr. Strüngmann currently holds the position of Co-Managing Director at Klinge Pharma GmbH (Bayern).
Former positions include Chairman at Eon Labs, Inc., Chairman-Supervisory Board at Santo Holding AG, Co-Managing Director at ATHOS Service GmbH, Co-Managing Director at Jossa Arznei GmbH, Co-Managing Director at AT Impf GmbH, Member-Supervisory Board at Wacker Chemie AG, and Member-Supervisory Board at Formycon AG from 2022 to 2023.
Education includes a doctorate from the University of Augsburg and undergraduate studies at Ludwig-Maximilians-Universität München.